AAV-FGF (Schering AG)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV-FGF (Schering AG)
Drug Alias NameAAV gene therapy (Schering AG)multiple sclerosis gene therapy(Schering AG)
ClassificationBiologics
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A